Comparable stake leader
Brian M. Isern
SEC ownership of Tricida, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001595585.
Disclosed value leader
—
Comparable rows
0/12
Latest evidence
24 Oct 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Brian M. Isern
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
24 Oct 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001595585
- Issuer location
- South San Francisco, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Tricida, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Brian M. Isern
Disclosed value leader
—
Comparable rows
0/12
Latest evidence
24 Oct 2022
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
12 rows are not safely comparable across share classes.
Showing 1-8 of 12 holder rows.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Brian M. Isern's linked filing trail.
Detailed SEC evidence table Showing 1-8 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Brian M. Isern |
3/4/5
*possible member of 10% group, 10%+ Owner
|
—
class O/S missing
|
—
5,563,493 shares
|
— | 11 Oct 2022 |
| Venrock Healthcare Capital Partners II, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,751,406 shares
|
— | 24 Oct 2022 |
| Sandra I. Coufal |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
| Gerrit Klaerner |
3/4/5
President and CEO, Director
|
—
class O/S missing
|
—
511,000 shares
|
— | 28 Feb 2022 |
| Dawn Parsell Otto |
3/4/5
EVP, Clinical Development
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| Mr. Geoffrey Parker |
3/4/5
COO, CFO and EVP
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| Robert McKague |
3/4/5
EVP, General Counsel
|
—
class O/S missing
|
—
256,000 shares
|
— | 28 Feb 2022 |
| David Hirsch |
3/4/5
Director
|
—
class O/S missing
|
—
27,207 shares
|
— | 15 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to Tricida, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
Klaus R. Dr Veitinger
Net 12M change
$0
Latest report
23 Nov 2022
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Klaus R. Dr Veitinger | Director | Mixed | 15 Jun 2022 | |||
| Sandra I. Coufal | Director, 10%+ Owner | Mixed | 15 Jun 2022 | |||
| David Hirsch | Director | Mixed | 15 Jun 2022 | |||
| Mr. Geoffrey Parker | COO, CFO and EVP | Mixed | 28 Feb 2022 | |||
| David P. Bonita | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Wilhelm Stahl | EVP, Chief Tech Officer | Mixed | 31 Dec 2021 | |||
| Kathryn E. Falberg | Director | Mixed | 15 Jun 2022 | |||
| Venrock Healthcare Capital Partners II, L.P. | 10%+ Owner | Mixed | 24 Oct 2022 | |||
| Robert J. Alpern | Director | Mixed | 23 Nov 2022 | |||
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Brian M. Isern | *possible member of 10% group, 10%+ Owner | Mixed | 11 Oct 2022 | |||
| Dawn Parsell Otto | EVP, Clinical Development | Mixed | 28 Feb 2022 | |||
| Robert McKague | EVP, General Counsel | Mixed | 28 Feb 2022 | |||
| Annie Yoshiyama | Senior VP, Finance and CAO | Mixed | 05 Aug 2022 | |||
| Gerrit Klaerner | President and CEO, Director | Mixed | 28 Feb 2022 |
Recent insider transactions for Tricida, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.